ACHN
TD Asset Management’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-208,587
| Closed | -$768K | – | 1460 |
|
|
2018
Q3 | $768K | Buy |
208,587
+3,100
| +2% | +$11.4K | ﹤0.01% | 1211 |
|
|
2018
Q2 | $582K | Buy |
205,487
+2,200
| +1% | +$6.23K | ﹤0.01% | 1239 |
|
|
2018
Q1 | $754K | Buy |
+203,287
| New | +$754K | ﹤0.01% | 1124 |
|
|
2016
Q4 | – | Sell |
-77,208
| Closed | -$625K | – | 1416 |
|
|
2016
Q3 | $625K | Sell |
77,208
-67,400
| -47% | -$546K | ﹤0.01% | 1116 |
|
|
2016
Q2 | $1.13M | Buy |
144,608
+1,508
| +1% | +$11.8K | ﹤0.01% | 944 |
|
|
2016
Q1 | $1.11M | Buy |
143,100
+18,500
| +15% | +$143K | ﹤0.01% | 944 |
|
|
2015
Q4 | $1.34M | Sell |
124,600
-2,100
| -2% | -$22.7K | ﹤0.01% | 894 |
|
|
2015
Q3 | $875K | Buy |
+126,700
| New | +$875K | ﹤0.01% | 949 |
|
|
2013
Q3 | – | Sell |
-45,400
| Closed | -$371K | – | 1283 |
|
|
2013
Q2 | $371K | Buy |
+45,400
| New | +$371K | ﹤0.01% | 992 |
|